SEMA5B inhibitors represent a class of chemical compounds designed to target and modulate the activity of the semaphorin 5B (SEMA5B) protein. Semaphorins are a family of secreted and membrane-bound proteins that play crucial roles in axon guidance, neuronal development, and tissue morphogenesis during embryonic and postnatal development. SEMA5B, specifically, is a transmembrane semaphorin known to influence axon pathfinding and cell migration. SEMA5B inhibitors are designed to interfere with the signaling pathways mediated by SEMA5B, thereby potentially influencing various cellular processes.
These inhibitors typically function by binding to SEMA5B or its receptors, disrupting the protein-protein interactions necessary for proper signaling. By doing so, SEMA5B inhibitors can potentially alter the guidance cues that govern axon growth and neuronal connectivity. In addition to their potential roles in neuronal development, SEMA5B inhibitors may have broader implications in other biological processes, such as immune response regulation and tissue regeneration. Research into the precise mechanisms and potential applications of SEMA5B inhibitors is ongoing, with the hope of uncovering their full range of functions and their relevance in various physiological and pathological contexts. Understanding the molecular intricacies of SEMA5B inhibition can offer valuable insights into the fundamental processes of cellular communication and may hold promise for future biomedical research.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which is part of the MAPK/ERK pathway, potentially modulating SEMA5B downstream effects. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which can alter the PI3K/Akt pathway, indirectly affecting SEMA5B-related signaling. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 inhibits MEK1/2, impacting the MAPK/ERK pathway and thereby potentially affecting SEMA5B-related cellular processes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which is a central regulator of cell growth and may indirectly influence SEMA5B signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor, altering the stress response pathway, which could indirectly modulate SEMA5B activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK, potentially affecting SEMA5B-related pathways by altering the cellular response to stress or cytokines. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor, impacting the PI3K/Akt pathway and possibly SEMA5B signaling. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
XAV-939 inhibits tankyrase, affecting the Wnt/β-catenin signaling pathway, which may cross-talk with SEMA5B-related pathways. | ||||||
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $96.00 $355.00 | 69 | |
BML-275 inhibits BMP signaling by targeting the kinases ALK2, ALK3, and ALK6, potentially affecting SEMA5B functions due to pathway interactions. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor, potentially affecting cytoskeletal dynamics and cellular processes that SEMA5B may influence. | ||||||